Publications by authors named "Ana Maria Regueira-Arcay"
J Clin Pharm Ther
June 2021
Article Synopsis
- The study analyzed potential drug-drug interactions (pDDIs) in COVID-19 patients, focusing on those treated with specific medications during the first wave of the pandemic.
- Out of 350 patients, 62.3% had at least one pDDI, with significant impacts noted on the QTc interval in a small fraction of patients, indicating potential risks.
- While the incidence of pDDIs was high, clinically significant adverse effects were relatively low, highlighting the need for careful monitoring of drug interactions in COVID-19 treatment.
